schema:articleBody
| - We will move the following business and economics stories: + Covid-19: As lab execs sell shares worth millions, questions arise + 'Strangled by debt': Coronavirus deepens Cambodia's loan crisis + Japan finds luring business from Hong Kong may be tough sell + Public money guarantees 'risky' fossil fuel projects: experts US-virus-pharmaceutical-health,FOCUS NEW YORK Pfizer, Moderna, Novavax: executives at several American laboratories developing Covid-19 vaccines have recently pocketed millions of dollars by selling shares in their companies -- raising questions about the propriety of such a move in the midst of a national health crisis. 750 words by Juliette Michel. Picture. File Picture Health-virus-Cambodia-economy-microfinance,FOCUS SIEM REAP Trapped under a mountain of crippling debt, Cambodian farmer Roeurn Reth fears she will have to sell her land to repay microfinance loans that have ballooned due to pandemic-spurred job losses in her family. 750 words by Suy Se. Picture. Video Japan-HongKong-China-economy-finance,FOCUS TOKYO Tokyo is on a charm offensive, hoping to lure firms in Hong Kong spooked by protests and a controversial security law imposed by China. But the city is proving a tough sell. 700 words by Etienne Balmer. File Picture Climate-environment-funding-gas-risk,FOCUS PARIS Energy firms are undertaking financially risky natural gas extraction projects from the Arctic to Africa made feasible by government-backed loans and guarantees, jeopardising efforts to curb global warming, experts say. 800 words by Eleonore Hughes afp
|